Total lymphoid irradiation: new therapeutic option for refractory giant cell myocarditis
- 30 April 2004
- journal article
- case report
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (4) , 492-495
- https://doi.org/10.1016/s1053-2498(03)00214-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Rapamycin reduces rejection in heart transplant recipientsTransplantation Proceedings, 2001
- Recurrence of giant cell myocarditis in cardiac allograftThe Journal of Heart and Lung Transplantation, 2001
- Rescue therapy: a role for sirolimus in lung and heart transplant recipientsTransplantation Proceedings, 2001
- Survival Outcomes of Patients with Giant Cell Myocarditis Bridged by Ventricular Assist DevicesAsaio Journal, 2000
- Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejectionThe Journal of Heart and Lung Transplantation, 2000
- Anti-CD2 Monoclonal Antibodies Prevent the Induction of Experimental Autoimmune Myocarditis.Japanese Heart Journal, 2000
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentNew England Journal of Medicine, 1997
- Anti-αβ T cell receptor antibody prevents the progression of experimental autoimmune myocarditisClinical and Experimental Immunology, 1994
- Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppressionEuropean Heart Journal, 1991
- Giant cell myocarditis: An autoimmune disease?American Heart Journal, 1988